|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 497-501, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
GA Crooke, LJ Harris, EA Grossi, FG Baumann, R Esposito, FC Spencer, SB Colvin and AC Galloway
The purpose of this study was to determine the effects of the addition of
amino acids to blood cardioplegic solution and the value of terminal
cardioplegia enhancement techniques in routine myocardial protection.
Forty-five open-chest adult dogs were instrumented with sonomicrometry
crystals to measure left ventricular long axis, midequatorial short axis,
and wall thickness. The aorta was clamped for 120 minutes of
cardiopulmonary bypass. Animals were randomly separated into four
myocardial protection groups: (1) blood cardioplegic solution with amino
acids and no terminal cardioplegia (n = 12); (2) blood cardioplegic
solution with amino acids and warm amino acid terminal cardioplegia (n =
11); (3) blood cardioplegic solution with amino acids and cold amino acid
terminal cardioplegia (n = 12); and (4) blood cardioplegic solution plus
cold terminal cardioplegia (no amino acids, n = 10). Data for preload
recruitable stroke work were obtained by inflow occlusion before bypass
(baseline) and at 30 and 60 minutes after reperfusion and analyzed for
changes in x-intercept and slope. A significant rightward shift in
x-intercept did not occur in any group. When cardiac function was expressed
as a percentage of baseline preload recruitable stroke work slope, improved
functional recovery was seen at both 30 and 60 minutes in groups 2 (88.6%
and 91.8%), 3 (85.8% and 86.9%), and 4 (88.6% and 92.6%) compared with
group 1 (77.3% and 79.2%, p < 0.05). No significant difference was found
in the degree of functional recovery among groups 2, 3, and 4. These
results suggest that for myocardial protection of 2 hours in nonischemic
hearts, a terminal dose of blood cardioplegic solution before unclamping is
beneficial, but this positive effect is independent of amino acid
supplementation and temperature.
ARTICLES
Role of amino acids and enhancement cardioplegia in routine myocardial protection. Experimental results
Department of Surgery, New York University Medical Center, NY 10016.
This article has been cited by other articles:
![]() |
C. Korvald, O. P. Elvenes, T. Myrmel, and D. G. Sorlie Cardiac dysfunction and inefficiency after substrate-enriched warm blood cardioplegia Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 555 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Ghomeshi, G. Tian, J. Ye, J. Sun, E. F. Hoffenberg, T. A. Salerno, and R. Deslauriers ASPARTATE/GLUTAMATE-ENRICHED BLOOD DOES NOT IMPROVE MYOCARDIAL ENERGY METABOLISM DURING ISCHEMIA-REPERFUSION: A 31P MAGNETIC RESONANCE SPECTROSCOPIC STUDY IN ISOLATED PIG HEARTS J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1068 - 1080. [Abstract] [Full Text] |
||||
![]() |
S. S. Sett, H. Tearle, and J. G. LeBlanc EFFECT OF GLUTAMATE-ASPARTATE REPERFUSION ON POSTISCHEMIC NEONATAL MYOCARDIUM J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 462 - 466. [Abstract] [Full Text] |
||||
![]() |
P. Menasche Blood Cardioplegia: Do We Still Need to Dilute? Ann. Thorac. Surg., October 1, 1996; 62(4): 957 - 960. [Full Text] |
||||
![]() |
T. Asai, E. A. Grossi, M. LeBoutillier III, M. A. Parish, F. G. Baumann, F. C. Spencer, S. B. Colvin, and A. C. Galloway Resuscitative retrograde blood cardioplegiaAre amino acids or continuous warm techniques necessary? J. Thorac. Cardiovasc. Surg., February 1, 1995; 109(2): 242 - 248. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |